Out-licensing
Coripharma develops generic oral solid dose pharmaceuticals available for out-licensing to European partners. Beyond the dossier, we provide regulatory support, patent landscape analysis, artwork design, and reliable manufacturing from our Icelandic facility. This comprehensive approach enables partners to launch differentiated products in their markets at patent expiry under their own brand.
Robust performance history
Our dedicated R&D team is involved at every stage of product development, bringing decades of pharmaceutical industry experience. Their track record demonstrates consistent success in developing quality generic products and delivering timely market launches across Europe.
R&D capability
Our Icelandic R&D facility specializes in tablet, capsule, and oral solid dose formulations, located next to our manufacturing site for seamless integration.
Our team manages the complete development cycle, from product selection and formulation through dossier completion and regulatory submissions. With full in-house capabilities, we maintain independence in our R&D workflow and respond effectively to regulatory requirements.